SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
26 hedge funds and large institutions have $44.5M invested in scPharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$989K | |
| 2 | +$391K | |
| 3 | +$281K | |
| 4 |
EP
Eversept Partners
New York
|
+$278K |
| 5 |
Morgan Stanley
New York
|
+$213K |
Top Sellers
| 1 | -$334K | |
| 2 | -$131K | |
| 3 | -$108K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$96K |
| 5 |
SG Americas Securities
New York
|
-$41K |